Mark Lubberink
Mark Lubberink
Dirección de correo verificada de - Página principal
Citado por
Citado por
Rapid decrease in delivery of chemotherapy to tumors after anti-VEGF therapy: implications for scheduling of anti-angiogenic drugs
AAM Van der Veldt, M Lubberink, I Bahce, M Walraven, MP de Boer, ...
Cancer cell 21 (1), 82-91, 2012
Altered myocardial substrate metabolism and decreased diastolic function in nonischemic human diabetic cardiomyopathy: studies with cardiac positron emission tomography and …
LJ Rijzewijk, RW van der Meer, HJ Lamb, HWAM de Jong, M Lubberink, ...
Journal of the American College of Cardiology 54 (16), 1524-1532, 2009
Blood–brain barrier P-glycoprotein function in Alzheimer's disease
DME van Assema, M Lubberink, M Bauer, WM van der Flier, RC Schuit, ...
Brain 135 (1), 181-189, 2012
Individualized dosimetry of kidney and bone marrow in patients undergoing 177Lu-DOTA-octreotate treatment
M Sandström, U Garske-Román, D Granberg, S Johansson, C Widström, ...
Journal of Nuclear Medicine 54 (1), 33-41, 2013
Pioglitazone improves cardiac function and alters myocardial substrate metabolism without affecting cardiac triglyceride accumulation and high-energy phosphate metabolism in …
RW van der Meer, LJ Rijzewijk, HWAM de Jong, HJ Lamb, M Lubberink, ...
Circulation 119 (15), 2069-2077, 2009
First-in-human molecular imaging of HER2 expression in breast cancer metastases using the 111In-ABY-025 affibody molecule
J Sörensen, D Sandberg, M Sandström, A Wennborg, J Feldwisch, ...
Journal of nuclear medicine 55 (5), 730-735, 2014
Measuring HER2-receptor expression in metastatic breast cancer using [68Ga] ABY-025 Affibody PET/CT
J Sörensen, I Velikyan, D Sandberg, A Wennborg, J Feldwisch, ...
Theranostics 6 (2), 262, 2016
In vivo visualization of amyloid deposits in the heart with 11C-PIB and PET
G Antoni, M Lubberink, S Estrada, J Axelsson, K Carlson, L Lindsjö, ...
Journal of Nuclear Medicine 54 (2), 213-220, 2013
Studies of a next-generation silicon-photomultiplier–based time-of-flight PET/CT system
DFC Hsu, E Ilan, WT Peterson, J Uribe, M Lubberink, CS Levin
Journal of Nuclear Medicine 58 (9), 1511-1518, 2017
Dose response of pancreatic neuroendocrine tumors treated with peptide receptor radionuclide therapy using 177Lu-DOTATATE
E Ilan, M Sandström, C Wassberg, A Sundin, U Garske–Román, ...
Journal of nuclear medicine 56 (2), 177-182, 2015
Effect of age on functional P‐glycoprotein in the blood‐brain barrier measured by use of (R)‐[11C]verapamil and positron emission tomography
R Toornvliet, BNM van Berckel, G Luurtsema, M Lubberink, AA Geldof, ...
Clinical Pharmacology & Therapeutics 79 (6), 540-548, 2006
Quantification, improvement, and harmonization of small lesion detection with state-of-the-art PET
CS van der Vos, D Koopman, S Rijnsdorp, AJ Arends, R Boellaard, ...
European journal of nuclear medicine and molecular imaging 44, 4-16, 2017
Quantitative and qualitative intrapatient comparison of 68Ga-DOTATOC and 68Ga-DOTATATE: net uptake rate for accurate quantification
I Velikyan, A Sundin, J Sörensen, M Lubberink, M Sandström, ...
Journal of Nuclear Medicine 55 (2), 204-210, 2014
Overeating saturated fat promotes fatty liver and ceramides compared with polyunsaturated fat: a randomized trial
F Rosqvist, J Kullberg, M Ståhlman, J Cedernaes, K Heurling, ...
The Journal of Clinical Endocrinology & Metabolism 104 (12), 6207-6219, 2019
Comparative biodistribution and radiation dosimetry of 68Ga-DOTATOC and 68Ga-DOTATATE in patients with neuroendocrine tumors
M Sandström, I Velikyan, U Garske-Román, J Sörensen, B Eriksson, ...
Journal of Nuclear Medicine 54 (10), 1755-1759, 2013
Automatic generation of absolute myocardial blood flow images using [15O]H2O and a clinical PET/CT scanner
HJ Harms, P Knaapen, S de Haan, R Halbmeijer, AA Lammertsma, ...
European journal of nuclear medicine and molecular imaging 38, 930-939, 2011
P-glycoprotein function at the blood–brain barrier: effects of age and gender
DME van Assema, M Lubberink, R Boellaard, RC Schuit, AD Windhorst, ...
Molecular imaging and biology 14, 771-776, 2012
Effects of hepatic triglyceride content on myocardial metabolism in type 2 diabetes
LJ Rijzewijk, JT Jonker, RW van der Meer, M Lubberink, HW de Jong, ...
Journal of the American College of Cardiology 56 (3), 225-233, 2010
Imaging in-vivo tau pathology in Alzheimer’s disease with THK5317 PET in a multimodal paradigm
K Chiotis, L Saint-Aubert, I Savitcheva, V Jelic, P Andersen, M Jonasson, ...
European journal of nuclear medicine and molecular imaging 43 (9), 1686-1699, 2016
Altered myocardial substrate metabolism is associated with myocardial dysfunction in early diabetic cardiomyopathy in rats: studies using positron emission tomography
CE van den Brom, MC Huisman, R Vlasblom, NM Boontje, S Duijst, ...
Cardiovascular diabetology 8, 1-12, 2009
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20